Acurx Pharmaceuticals
ACXP
ACXP
26 hedge funds and large institutions have $3.05M invested in Acurx Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
28% less capital invested
Capital invested by funds: $4.24M → $3.05M (-$1.19M)
Holders
26
Holding in Top 10
–
Calls
$117K
Puts
$104K
Top Buyers
| 1 | +$209K | |
| 2 | +$65.1K | |
| 3 | +$43.4K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$36.5K |
| 5 |
NS
NBC Securities
Birmingham,
Alabama
|
+$34K |
Top Sellers
| 1 | -$109K | |
| 2 | -$52.5K | |
| 3 | -$39.5K | |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$38.3K |
| 5 |
Morgan Stanley
New York
|
-$14.7K |